SOUTH KOREA – Samsung Biologics has completed the US$2.3 billion acquisition of Biogen’s stake in the Samsung Bioepis joint venture. Samsung Biologics signed a stake acquisition agreement in January of…
Read MoreTag: South Korea
SK Bioscience aims to become global biotech firm with new growth engine
SOUTH KOREA – SK Bioscience Co., a South Korean vaccine maker, has announced that it will broaden its business portfolio in order to secure a new growth engine, with the…
Read MoreWHO establishes global biomanufacturing training hub in Korea
SOUTH KOREA – The World Health Organization (WHO), the Republic of Korea, and the WHO Academy have announced the creation of a global biomanufacturing training hub to serve all low-…
Read MoreSamsung Biologics buys out Biogen in biosim venture for US$2.3B
SOUTH KOREA – Samsung Biologics announced that it has agreed to pay US$2.3 billion for Biogen’s stake in their nearly decade-long biosimilars joint venture Samsung Bioepis. The announcement follows a…
Read MoreSK commits US$350M for the construction of global cell and gene therapy CDMO
SOUTH KOREA – SK Inc. of South Korea has committed US$350 million in equity financing to the Center for Breakthrough Medicines (CBM) as part of the organizations’ partnership announced two…
Read MorePDC*line Pharma raises US$20.3 million in Series B2 financing round
BELGIUM – PDC*line Pharma, a clinical-stage biotech company developing a new class of potent and scalable active off-the-shelf cancer vaccine, has completed its Series B2 round of funding, raising €17.5…
Read MoreRoche’s arthritis drug scores EMA approval for treating severe Covid-19
NETHERLANDS – The European Medicines Agency (EMA) has recommended extending the use of Roche’s RoActemra arthritis drug for adult COVID-19 patients receiving systemic steroid treatment and those requiring oxygen support…
Read MorePfizer applies for emergency use authorization of its novel COVID-19 pill
USA – Pfizer, a US-based pharmaceutical giant has asked the Food and Drug Administration to approve its experimental COVID-19 pill for emergency use, setting the stage for a likely launch…
Read MoreMerck’s oral antiviral pill grabs UK’s Emergency Use Approval in adults
UNITED KINGDOM – Britain has become the first country in the world to approve a potentially game-changing COVID-19 antiviral oral pill developed in collaboration by Merck and Ridgeback Biotherapeutics, providing…
Read MoreSamsung Biologics rolls out the supply of domestically-manufactured Moderna vaccines in South Korea
SOUTH KOREA – Samsung Biologics, a major South Korean contract drug manufacturer, has rolled out supplies of the first batch of domestically-made Moderna vaccines. Moderna’s COVID-19 vaccine, manufactured by Samsung…
Read More